IRD
Opus Genetics
IRD
IRD
38 hedge funds and large institutions have $3.32M invested in Opus Genetics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $4.13M → $3.32M (-$811K)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Holders
38
Holding in Top 10
–
Calls
$18K
Puts
$1K
Top Buyers
| 1 | +$95.3K | |
| 2 | +$37.9K | |
| 3 | +$36.5K | |
| 4 |
VF
Virtu Financial
New York
|
+$31K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$15.4K |
Top Sellers
| 1 | -$342K | |
| 2 | -$64.8K | |
| 3 | -$46.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13.1K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$13.1K |